High survival rate with the LMT-89 regimen in lymphoblastic lymphoma (LL), but not in T-cell acute lymphoblastic leukemia (T-ALL)

Leukemia
E JabbourV Ribrag

Abstract

The most appropriate treatment for lymphoblastic lymphomas (LL) remains uncertain. We treated 27 patients with newly diagnosed LL according to an LMT-89 protocol, which is a modified version of the LMT-81 protocol previously reported in pediatric patients. The median age was 31 years. Mediastinal enlargement was present in 25/27 patients, with pleural effusion in 12. Four patients had central nervous system involvement and 12 had bone marrow involvement and 24/27 (89%) had advanced Ann Arbor stage III-IV disease. Complete remission (CR) was achieved in 20/27 patients, unconfirmed complete remission in three patients (residual mediastinal lesion on computed tomography scan) and four failed induction therapy (ORR: 85%). Twelve patients (44%) remained in continuous CR with a median follow-up of 95 months. Survival at 3 years (when all the events occurred in our series) was 63%. Bone marrow involvement was associated with a poor outcome. Overall survival was 85+/-20% in patients without bone marrow involvement compared to 37+/-30% in patients with bone marrow involvement. The Ann Arbor stage, age and serum lactate dehydrogenase level did not influence outcomes. This LMT-89 protocol is a safe regimen and is highly effective in advan...Continue Reading

References

Nov 1, 1992·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R ChopraP Ernst
Jul 1, 1992·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P MorelC Gisselbrecht
Jan 1, 1990·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C BernasconiE Orlandi
Jan 1, 1986·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D E SlaterZ Arlin
Nov 1, 1986·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C N ColemanS A Rosenberg
Jun 22, 1974·British Medical Journal·D CatovskyD A Galton
Dec 1, 1981·Cancer·B N NathwaniH Rappaport
Jul 29, 1998·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R BouabdallahJ A Gastaut
Aug 15, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J O Armitage, D D Weisenburger
Mar 20, 2001·Hematology/oncology Clinics of North America·D A Thomas, H M Kantarjian
Oct 12, 2002·Medical and Pediatric Oncology·Andishe AttarbaschiHelmut Gadner
Jun 5, 2004·Blood·Deborah A ThomasHagop Kantarjian

❮ Previous
Next ❯

Citations

Aug 26, 2014·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Il Hwan RyuDong Wook Kang
Sep 26, 2012·The Cancer Journal·Craig A Portell, John W Sweetenham
Jan 29, 2011·Critical Reviews in Oncology/hematology·Sergio CortelazzoDieter Hoelzer
Sep 26, 2009·Clinical Lymphoma & Myeloma·Dieter Hoelzer, Nicola Gökbuget
Nov 13, 2015·Pediatric Hematology and Oncology·Marina ServitzoglouCécile Thomas-Teinturier
Oct 29, 2008·Hematology/oncology Clinics of North America·John W Sweetenham
Dec 19, 2015·European Journal of Haematology·Renato BassanSergio Cortelazzo
Jun 3, 2016·Leukemia & Lymphoma·Juan Pablo AlderuccioIzidore S Lossos
Jun 25, 2016·Journal of the Egyptian National Cancer Institute·Hany Abdel Rahman SayedDina Hesham
Apr 17, 2017·Experimental Hematology·Stéphane LepretreNicolas Boissel
Jul 25, 2017·European Journal of Nuclear Medicine and Molecular Imaging·Stéphanie BeckerStéphane Lepretre
Feb 5, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Frederic BaleydierElizabeth Macintyre

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.